603 related articles for article (PubMed ID: 19747492)
1. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
Boettler T; von Herrath M
Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
[TBL] [Abstract][Full Text] [Related]
4. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
5. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for the prevention and treatment of type 1 diabetes.
Goudy KS; Tisch R
Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell replacement for insulin-dependent diabetes mellitus.
Efrat S
Adv Drug Deliv Rev; 2008 Jan; 60(2):114-23. PubMed ID: 18022276
[TBL] [Abstract][Full Text] [Related]
8. Rehabilitation of adaptive immunity and regeneration of beta cells.
Pasquali L; Fan Y; Trucco M; Ringquist S
Trends Biotechnol; 2006 Nov; 24(11):516-22. PubMed ID: 16963140
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
[TBL] [Abstract][Full Text] [Related]
10. Cell therapy for diabetes: stem cells, progenitors or beta-cell replication?
Gonez LJ; Knight KR
Mol Cell Endocrinol; 2010 Jul; 323(1):55-61. PubMed ID: 20026173
[TBL] [Abstract][Full Text] [Related]
11. Are stem cells a cure for diabetes?
McCall MD; Toso C; Baetge EE; Shapiro AM
Clin Sci (Lond); 2009 Oct; 118(2):87-97. PubMed ID: 19807695
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells in type 1 diabetes.
Tsai S; Shameli A; Santamaria P
Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
Limbert C; Päth G; Jakob F; Seufert J
Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
[TBL] [Abstract][Full Text] [Related]
14. Generation of insulin-producing beta cells from stem cells--perspectives for cell therapy in type 1 diabetes.
Seissler J; Schott M
Horm Metab Res; 2008 Feb; 40(2):155-61. PubMed ID: 18283634
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
Phillips BE; Giannoukakis N; Trucco M
Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy.
Hansson M; Madsen OD
Curr Opin Investig Drugs; 2010 Apr; 11(4):417-25. PubMed ID: 20336589
[TBL] [Abstract][Full Text] [Related]
17. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
18. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
[TBL] [Abstract][Full Text] [Related]
20. The potential role of dendritic cells in the therapy of Type 1 diabetes.
Lee CN; Lew AM; Wu L
Immunotherapy; 2013 Jun; 5(6):591-606. PubMed ID: 23725283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
